Erdheim-Chester disease: report on a case and new insights on its immunopathogenesis
Open Access
- 22 January 2010
- journal article
- research article
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 49 (6) , 1203-1206
Abstract
Sir, Erdheim–Chester disease (ECD) is a rare (approximately 350 published cases worldwide) non-Langerhans cell histiocytosis (LCH) characterized by tissue infiltration with CD68+, CD1a− foamy histiocytes. The disease almost invariably affects bones, causing the nearly pathognomonic osteosclerosis of the limbs. In addition, ECD patients frequently have extra-skeletal manifestations, including exophthalmos, xanthelasma, interstitial lung disease, retroperitoneal fibrosis, pituitary and hypothalamic infiltration and central nervous system and cardiovascular involvements [1–3]. IFN-α represents the best available treatment [4], but response to therapy varies among patients and according to the sites of involvement [5].Keywords
This publication has 10 references indexed in Scilit:
- Increased serum monocyte chemoattractant protein‐1, macrophage inflammatory protein‐1β, and interleukin‐8 concentrations in hemophagocytic lymphohistiocytosisPediatric Blood & Cancer, 2008
- TNF activates an IRF1-dependent autocrine loop leading to sustained expression of chemokines and STAT1-dependent type I interferon–response genesNature Immunology, 2008
- Bilateral Adrenal Infiltration in Erdheim-Chester Disease. Report of Seven Cases and Literature ReviewThe Journal of Clinical Endocrinology & Metabolism, 2007
- Immunohistochemical evidence of a cytokine and chemokine network in three patients with Erdheim‐Chester disease: Implications for pathogenesisArthritis & Rheumatism, 2006
- Variability in the efficacy of interferon‐α in Erdheim‐Chester disease by patient and site of involvement: Results in eight patientsArthritis & Rheumatism, 2006
- Successful treatment of Erdheim-Chester disease, a non–Langerhans-cell histiocytosis, with interferon-αBlood, 2005
- Langerhans-cell histiocytosis 'insight into DC biology'Trends in Immunology, 2003
- Skewing of cytotoxic activity and chemokine production, but not of chemokine receptor expression, in human type-1/-2 γ δ T lymphocytesEuropean Journal of Immunology, 2002
- Erdheim-Chester Disease: A Primary Macrophage Cell DisorderAmerican Journal of Respiratory and Critical Care Medicine, 1998
- Erdheim-Chester Disease Clinical and Radiologic Characteristics of 59 CasesMedicine, 1996